| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 115.3 | 134.9 | 138.7 |
| Other income | 0.8 | 0.8 | 1.1 |
| Total income | 116.2 | 135.6 | 139.8 |
| Profit before exceptional items & tax | 3.5 | 2.2 | 2.8 |
| Profit before tax | 3.5 | 2.2 | 2.8 |
| Net profit | 2.5 | 1.6 | 2.2 |
| Operating margin | 3.0% | 1.6% | 2.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +13.60% |
|---|---|
| Net profit, quarter on quarter | +56.20% |
| Revenue, year on year | -16.90% |
NSE results filing, NSE: AUROIMPEX. Figures extracted from the filing.
Auro Impex & Chemicals Ltd: key numbers
- Share price
- ₹42.95
- Market cap
- ₹52.40 Cr
- Revenue (annual)
- ₹250.2 Cr
- Net profit (annual)
- ₹4.16 Cr
- P/E (TTM)
- 12.6×Sector 53.6×
- Promoter holding
- 71.62%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Auro Impex & Chemicals Ltd
All →Auro Impex & Chemicals Annual General Meeting
Auro Impex & Chemicals Limited will hold an EGM on October 15, 2026. Shareholders will vote on changing the company name and altering its main objects clause.
Auro Impex & Chemicals Price Movement Clarification
Auro Impex & Chemicals Limited clarified to the NSE that recent stock price movements are market-driven and not due to any undisclosed material information.
Auro Impex & Chemicals Annual General Meeting
Auro Impex & Chemicals Limited held its 33rd Annual General Meeting on September 12, 2026. The meeting transacted several ordinary and special business resolutions.
Auro Impex & Chemicals Board Meeting Outcome
The board approved revision of MD's remuneration, pending shareholder approval at the upcoming EGM. The first EGM was scheduled for 15 October 2026 via OAVM.
Auro Impex & Chemicals Board Meeting Outcome
The board approved changing the company name to 'Auro Impex & Power Limited,' altering the main object clause, and amending the MD's appointment terms.